These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles. Breese GR; Knapp DJ; Criswell HE; Moy SS; Papadeas ST; Blake BL Brain Res Brain Res Rev; 2005 Feb; 48(1):57-73. PubMed ID: 15708628 [TBL] [Abstract][Full Text] [Related]
3. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats. Criswell HE; Johnson KB; Mueller RA; Breese GR J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756 [TBL] [Abstract][Full Text] [Related]
4. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 1. Dopaminergic neurons and receptors. Yokoyama C; Okamura H J Pharmacol Exp Ther; 1997 Feb; 280(2):1016-30. PubMed ID: 9023319 [TBL] [Abstract][Full Text] [Related]
5. Role of NMDA and AMPA glutamate receptors in the induction and the expression of dopamine-mediated sensitization in 6-hydroxydopamine-lesioned rats. Pollack AE; St Martin JL; MacPherson AT Synapse; 2005 Apr; 56(1):45-53. PubMed ID: 15700284 [TBL] [Abstract][Full Text] [Related]
6. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats. Shuto T; Seeman P; Kuroiwa M; Nishi A Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579 [TBL] [Abstract][Full Text] [Related]
7. Priming of D1-dopamine receptor responses: long-lasting behavioral supersensitivity to a D1-dopamine agonist following repeated administration to neonatal 6-OHDA-lesioned rats. Criswell H; Mueller RA; Breese GR J Neurosci; 1989 Jan; 9(1):125-33. PubMed ID: 2521511 [TBL] [Abstract][Full Text] [Related]
8. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development. Neal-Beliveau BS; Joyce JN Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220 [TBL] [Abstract][Full Text] [Related]
9. Postnatal administration of D1 dopamine agonist reverses neonatal dopaminergic lesion-induced changes in striatal enkephalin and substance P systems. Sivam SP; Cox J Brain Res; 2006 Feb; 1073-1074():159-63. PubMed ID: 16455064 [TBL] [Abstract][Full Text] [Related]
10. Assessment of purine-dopamine interactions in 6-hydroxydopamine-lesioned rats: evidence for pre- and postsynaptic influences by adenosine. Criswell H; Mueller RA; Breese GR J Pharmacol Exp Ther; 1988 Feb; 244(2):493-500. PubMed ID: 3126293 [TBL] [Abstract][Full Text] [Related]
11. Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32. Flores-Hernández J; Cepeda C; Hernández-Echeagaray E; Calvert CR; Jokel ES; Fienberg AA; Greengard P; Levine MS J Neurophysiol; 2002 Dec; 88(6):3010-20. PubMed ID: 12466426 [TBL] [Abstract][Full Text] [Related]
12. Limbic pallidal adaptations following long-term cessation of dopaminergic transmission: lack of upregulation of dopamine receptor function. Heidenreich BA; Mitrovic I; Battaglia G; Napier TC Exp Neurol; 2004 Apr; 186(2):145-57. PubMed ID: 15026253 [TBL] [Abstract][Full Text] [Related]
13. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 2. Intracerebral microinjection of dopamine agonists and antagonists. Okamura H; Murakami T; Yokoyama C; Nakamura T; Ibata Y J Pharmacol Exp Ther; 1997 Feb; 280(2):1031-7. PubMed ID: 9023320 [TBL] [Abstract][Full Text] [Related]
14. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons. Van De Witte SV; Groenewegen HJ; Voorn P Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728 [TBL] [Abstract][Full Text] [Related]
15. Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism. St-Hilaire M; Landry E; Lévesque D; Rouillard C Neurobiol Dis; 2005 Nov; 20(2):450-60. PubMed ID: 15896973 [TBL] [Abstract][Full Text] [Related]
17. Opiate anti-nociception is attenuated following lesion of large dopamine neurons of the periaqueductal grey: critical role for D1 (not D2) dopamine receptors. Flores JA; El Banoua F; Galán-Rodríguez B; Fernandez-Espejo E Pain; 2004 Jul; 110(1-2):205-14. PubMed ID: 15275769 [TBL] [Abstract][Full Text] [Related]
18. Increased behavioral response to dopaminergic stimulation of the subthalamic nucleus after nigrostriatal lesions. Mehta A; Thermos K; Chesselet MF Synapse; 2000 Sep; 37(4):298-307. PubMed ID: 10891867 [TBL] [Abstract][Full Text] [Related]
19. Interactive modulation by dopamine and serotonin neurons of receptor sensitivity of the alternate neurochemical system. Kostrzewa RM; Brus R; Perry KW Pol J Pharmacol; 1999; 51(1):39-47. PubMed ID: 10389143 [TBL] [Abstract][Full Text] [Related]